Reduction in the circulating pDC1/pDC2 ratio and impaired function of Ex Vivo-generated DC1 in chronic hepatitis B infection

Clinical Immunology

Volumn 104, Issue 2, 2002, Pages 138-150

  Beckebaum, Susanne ^a   Cicinnati, Vito R ^a,b   Dworacki, Grzegorz ^a,b   Müller Berghaus, Jan ^a   Stolz, Donna ^a   Harnaha, Jo ^a   Whiteside, Theresa L ^b   Thomson, Angus W ^a   Lu, Lina ^a   Fung, John J ^a   Bonham, C Andrew ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

Allostimulation; Antigen presentation; EM; IFN ; IL 12; Liver; Viral infection

Indexed keywords

B7 ANTIGEN; CD86 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 12;

ADULT; ANTIGEN PRESENTATION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; FEMALE; FLOW CYTOMETRY; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOSTIMULATION; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; VIRUS INFECTION; VIRUS PARTICLE;

EID: 0036046189     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1006/clim.2002.5245     Document Type: Article

References (67)

1. Natural history of hepatitis B and C virus infection
2. Pathogenesis of hepatocellular carcinoma
3. Therapy of viral hepatitis
4. Molecular analysis of hepatitis B virus DNA in serum and peripheral blood mononuclear cells from hepatitis B surface antigen-negative cases
5. Hepatitis B virus DNA in peripheral-blood mononuclear cells in chronic hepatitis B after HBsAg clearance
6. Persistence of free HBV DNA in body secretions and liver despite loss of serum HBV DNA after interferon-induced seroconversion
7. Hepatitis B immunopathogenesis
8. Direct ex vivo analysis of hepatitis B virus-specific CD8(+) T cells associated with the control of infection
9. Incubation phase of acute hepatitis B in man: Dynamic of cellular immune mechanisms
10. Hepatitis B virus transgenic mice: Models of viral immunobiology and pathogenesis
11. Viral clearance without destruction of infected cells during acute HBV infection
12. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes
13. The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection
14. Dendritic cells
15. Liver-derived DEC205+B220+CD19-dendritic cells regulate T cell responses
16. Effects of liver-derived dendritic cell progenitors on Th1- and Th2- like cytokine responses in vitro and in vivo
17. The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand
18. Dendritic cells as regulators of immune reactivity: Implications for transplantation
19. Reciprocal control of T helper cell and dendritic cell differentiation
20. Flt3-ligand and granulocyte colony- stimulating factor mobilize distinct human dendritic cell subsets in vivo
21. Granulocyte-colony stimulating factor mobilizes T helper 2-inducing dendritic cells
22. Predominant T-helper 1 cytokine profile of hepatitis B virus nucleocapsid-specific T cells in acute self-limited hepatitis B
23. Impaired allostimulatory capacity of peripheral blood dendritic cells recovered from hepatitis C virus-infected individuals
24. Impaired allostimulatory function of dendritic cells in chronic hepatitis C infection
25. Impaired dendritic cell maturation in patients with chronic, but not resolved, hepatitis C virus infection
26. Infection of dendritic cells with HIV1: Virus load regulates stimulation and suppression of T-cell activity
27. Measles virus infects human dendritic cells and blocks their allostimulatory properties for CD4+ T cells
28. Rare-event analysis of circulating human dendritic cell subsets and their presumptive mouse counterparts
29. Human blood contains two subsets of dendritic cells, one immunologically mature and the other immature
30. A flow cytometric immune function assay for human peripheral blood dendritic cells
31. Proliferating dendritic cell progenitors in human blood
32. Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions
33. Lack of evidence for hepatitis B virus (HBV) infection in fulminant non-A, non-B hepatitis
34. Nucleotide sequence analysis of precore and proximal core regions in patients with chronic hepatitis B treated with interferon
35. Head-to-tail primer tandem repeats generated in heminested PCR
36. Molecular basis for persistent hepatitis B virus infection in the liver after clearance of serum hepatitis B surface antigen
37. Human thymus contains IFN-alpha-producing CD11c(-), myeloid CD11c(+), and mature interdigitating dendritic cells
38. Generation of interferon alpha-producing predendritic cell (Pre-DC)2 from human CD34(+) hematopoietic stem cells
39. Human blood dendritic cells selectively express CD 83, a member of the immunoglobulin superfamily
40. Persistence of hepatitis B virus DNA in serum and liver from patients with chronic hepatitis B after loss of HBsAg
41. Serum and liver hepatitis B virus DNA in chronic hepatitis B after sustained loss of surface antigen
42. The hepatitis B virus and the peripheral blood mononuclear cells: A brief review
43. Detection of hepatitis B virus DNA in mononuclear blood cells
44. Electron microscopy studies of severe virus hepatitis: Cytoplasmic inclusions, virus-like particles, Australia antigen
45. Electron and immunoelectron microscopic study of Dane particle formation in chronic hepatitis B virus infection
46. Virus-like particles in serum of patients with Australia-antigen-associated hepatitis
47. The nature of the principal type 1 interferon-producing cells in human blood
48. Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B
49. Dendritic cells and the control of immunity
50. Low levels of interferon-alpha induce CD86 (B7.2) expression and accelerate dendritic cell maturation from human peripheral blood mononuclear cells
51. Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematodes
52. Generation of monocyte-derived dendritic cells from patients with renal cell cancer: Modulation of their functional properties after therapy with biological response modifiers (IFN-alpha plus IL-2 and IL-12)
53. Clonal heterogenicity of dendritic cells derived from patients with chronic myeloid leukemia and enhancement of their T-cells stimulatory activity by IFN-alpha
54. Interferon-α and -β inhibit the in vitro differentiation of immunocompetent human dendritic cells from CD14+ precursors
55. Predictability of alloreactivity among unrelated individuals: Role for HLA-DPB1
56. Dendritic cells with immature phenotype and defective function in the peripheral blood from patients with hepatocellular carcinoma
57. The role of interleukin 12 in the immune response, disease and therapy
58. Human monocyte-derived dendritic cells induce naive T cell differentiation into T helper cell type 2 (Th2) or Th1/ Th2 effectors: Role of stimulator/responder ratio
59. State of hepatitis B virus DNA in leucocytes of hepatitis B patients
60. Hepatitis B virus DNA in mononuclear cells and analysis of cell subsets for the presence of replicative intermediates of viral DNA
61. Productive infection of dendritic cells by HIV- 1 and their ability to capture virus are mediated through separate pathways
62. Measles virus suppresses cell-mediated immunity by interfering with the survival and functions of dendritic and T cells
63. Monocyte-derived dendritic cells are permissive to the complete replicative cycle of human cytomegalovirus
64. Vaccinia virus inhibits the maturation of human dendritic cells: A novel mechanism of immune evasion
65. Mature dendritic cells infected with herpes simplex virus type 1 exhibit inhibited T-cell stimulatory capacity
66. Human skin Langerhans cells are targets of dengue virus infection